These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 33455988)

  • 1. Intravenous Mineralocorticoid Receptor Antagonist Use in Acutely Decompensated Heart Failure with Diuretic Resistance.
    Girerd N; Aubry M; Lantelme P; Huttin O; Rossignol P
    Int Heart J; 2021 Jan; 62(1):193-196. PubMed ID: 33455988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure.
    Kissling KT; Pickworth KK
    Pharmacotherapy; 2014 Aug; 34(8):882-7. PubMed ID: 24990816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with acute heart failure treated with the CARRESS-HF diuretic protocol in association with canrenoate potassium: Tolerance of high doses of canrenoate potassium.
    Berger C; Prieur C; Bochaton T; Berthiller J; Luyt CE; Bonnefoy-Cudraz E
    Arch Cardiovasc Dis; 2020 Nov; 113(11):679-689. PubMed ID: 32948466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.
    Givertz MM; Massie BM; Fields TK; Pearson LL; Dittrich HC;
    J Am Coll Cardiol; 2007 Oct; 50(16):1551-60. PubMed ID: 17936154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effects and safety of different strategies for administering intravenous diuretics in acutely decompensated heart failure: a randomised clinical trial.
    Llorens P; Miró Ò; Herrero P; Martín-Sánchez FJ; Jacob J; Valero A; Alonso H; Pérez-Durá MJ; Noval A; Gil-Román JJ; Zapater P; Llanos L; Gil V; Perelló R
    Emerg Med J; 2014 Sep; 31(9):706-13. PubMed ID: 23793945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diuretic therapy in acute heart failure].
    Trullàs JC; Morales-Rull JL; Formiga F
    Med Clin (Barc); 2014 Mar; 142 Suppl 1():36-41. PubMed ID: 24930082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramuscular bumetanide and furosemide in congestive heart failure.
    Abrams J
    J Clin Pharmacol; 1981; 21(11):673-9. PubMed ID: 7338578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and Design of the "Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:" A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combined Diuretic Therapy (Loop Diuretics With Thiazide-Type Diuretics) Among Patients With Decompensated Heart Failure.
    Trullàs JC; Morales-Rull JL; Casado J; Freitas Ramírez A; Manzano L; Formiga F;
    J Card Fail; 2016 Jul; 22(7):529-36. PubMed ID: 26576715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of three diuretic treatment strategies for patients with acute decompensated heart failure.
    Yayla Ç; Akyel A; Canpolat U; Gayretli Yayla K; Eyiol A; Akboğa MK; Türkoğlu S; Tavil Y; Boyacı B; Çengel A
    Herz; 2015 Dec; 40(8):1115-20. PubMed ID: 26135463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralocorticoid receptor antagonists as diuretics: Can congestive heart failure learn from liver failure?
    Masoumi A; Ortiz F; Radhakrishnan J; Schrier RW; Colombo PC
    Heart Fail Rev; 2015 May; 20(3):283-90. PubMed ID: 25447845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational use of diuretics in acute decompensated heart failure.
    Goebel JA; Van Bakel AB
    Curr Heart Fail Rep; 2008 Sep; 5(3):153-62. PubMed ID: 18752765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure.
    Ferreira JP; Santos M; Almeida S; Marques I; Bettencourt P; Carvalho H
    Eur J Intern Med; 2014 Jan; 25(1):67-72. PubMed ID: 24070521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bumetanide--a new potent diuretic for oral and intravenous use].
    Johansson BW
    Lakartidningen; 1975 Sep; 72(37):3413-6. PubMed ID: 1099368
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure.
    Dormans TP; Gerlag PG
    Eur Heart J; 1996 Dec; 17(12):1867-74. PubMed ID: 8960430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A diuretic protocol increases volume removal and reduces readmissions among hospitalized patients with acute decompensated heart failure.
    Barsuk JH; Gordon RA; Cohen ER; Cotts WG; Malkenson D; Yancy CW; Williams MV
    Congest Heart Fail; 2013; 19(2):53-60. PubMed ID: 23336425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Intravenous Chlorothiazide versus Oral Metolazone in Patients with Acute Decompensated Heart Failure and Loop Diuretic Resistance.
    Shulenberger CE; Jiang A; Devabhakthuni S; Ivaturi V; Liu T; Reed BN
    Pharmacotherapy; 2016 Aug; 36(8):852-60. PubMed ID: 27393709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial.
    Angeli P; Fasolato S; Mazza E; Okolicsanyi L; Maresio G; Velo E; Galioto A; Salinas F; D'Aquino M; Sticca A; Gatta A
    Gut; 2010 Jan; 59(1):98-104. PubMed ID: 19570764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative randomized double-blind clinical trial of bumetanide and furosemide in congestive cardiac failure and other edema states.
    Sagar S; Sharma BK; Sharma PL; Wahi PL
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):473-8. PubMed ID: 6389378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diuretic action of bumetanide in congestive heart failure.
    Olsen KH; Sigurd B; Hesse B; Steiness E; Leth A
    Postgrad Med J; 1975; 51 Suppl 6():54-63. PubMed ID: 1105534
    [No Abstract]   [Full Text] [Related]  

  • 20. Bumetanide, a new potent diuretic. A clinical evaluation in congestive heart failure.
    Olesen KH; Sigurd B; Steiness E; Leth A
    Acta Med Scand; 1973; 193(1-2):119-31. PubMed ID: 4574445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.